Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis
Primary sclerosing cholangitis (PSC) is an idiopathic, progressive, cholestatic liver disease with considerable morbidity and mortality and no established pharmacotherapy. In addition to the long-recognized association between PSC and inflammatory bowel disease, several lines of preclinical and clin...
Main Authors: | James H. Tabibian, Jayant A. Talwalkar, Keith D. Lindor |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/389537 |
Similar Items
Similar Items
-
Primary sclerosing cholangitis
by: Marina G Silveira, et al.
Published: (2008-01-01) -
Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis
by: James H. Tabibian, M.D., et al.
Published: (2014-05-01) -
Cholangioscopy and its Role in Primary Sclerosing Cholangitis
by: Brian M. Fung, et al.
Published: (2020-06-01) -
Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis
by: Moira Hilscher, et al.
Published: (2016-03-01) -
Primary sclerosing cholangitis: A review and update
by: James H. Tabibian, et al.
Published: (2017-12-01)